1. Home
  2. NDAQ vs IQV Comparison

NDAQ vs IQV Comparison

Compare NDAQ & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDAQ
  • IQV
  • Stock Information
  • Founded
  • NDAQ 1971
  • IQV 1982
  • Country
  • NDAQ United States
  • IQV United States
  • Employees
  • NDAQ N/A
  • IQV N/A
  • Industry
  • NDAQ Investment Bankers/Brokers/Service
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • NDAQ Finance
  • IQV Health Care
  • Exchange
  • NDAQ Nasdaq
  • IQV Nasdaq
  • Market Cap
  • NDAQ 43.7B
  • IQV 35.7B
  • IPO Year
  • NDAQ 2002
  • IQV 2013
  • Fundamental
  • Price
  • NDAQ $78.83
  • IQV $197.47
  • Analyst Decision
  • NDAQ Buy
  • IQV Strong Buy
  • Analyst Count
  • NDAQ 16
  • IQV 17
  • Target Price
  • NDAQ $85.73
  • IQV $255.88
  • AVG Volume (30 Days)
  • NDAQ 2.7M
  • IQV 1.3M
  • Earning Date
  • NDAQ 01-29-2025
  • IQV 02-12-2025
  • Dividend Yield
  • NDAQ 1.22%
  • IQV N/A
  • EPS Growth
  • NDAQ N/A
  • IQV 27.98
  • EPS
  • NDAQ 1.68
  • IQV 7.62
  • Revenue
  • NDAQ $7,017,000,000.00
  • IQV $15,315,000,000.00
  • Revenue This Year
  • NDAQ N/A
  • IQV $3.67
  • Revenue Next Year
  • NDAQ $7.64
  • IQV $4.53
  • P/E Ratio
  • NDAQ $46.88
  • IQV $25.90
  • Revenue Growth
  • NDAQ 16.97
  • IQV 3.10
  • 52 Week Low
  • NDAQ $54.90
  • IQV $187.62
  • 52 Week High
  • NDAQ $83.77
  • IQV $261.73
  • Technical
  • Relative Strength Index (RSI)
  • NDAQ 54.16
  • IQV 45.36
  • Support Level
  • NDAQ $75.33
  • IQV $194.06
  • Resistance Level
  • NDAQ $78.34
  • IQV $207.72
  • Average True Range (ATR)
  • NDAQ 1.23
  • IQV 4.74
  • MACD
  • NDAQ 0.14
  • IQV 0.12
  • Stochastic Oscillator
  • NDAQ 86.63
  • IQV 27.90

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: